Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)

NCT03100045 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

HPV-Related Anal Intraepithelial Neoplasia
AIN2/3
Artesunate
Alternative Treatment
Anal Dysplasia
Precancerous Conditions
Human Papilloma Virus

Interventions

DRUG: Artesunate Suppositories

Sponsor

Johns Hopkins University

Collaborators

[object Object]
[object Object]